• Management
  • Asymptomatic
    • An Automated implantable cardioverter defibrillator (AICD) is considered for primary or secondary prevention of sudden cardiac death in patients who are at high risk.
      • Absolute indication: known prior history of ventricular fibrillation, sustained ventricular tachycardia, or cardiac arrest
      • Relative indications
        • Syncope of unknown cause
        • Family history of SCD in a first-degree relative
        • LV wall thickness ≥ 30 mm
    • 🍒What should you consider as part of management for hypertrophic cardiomyopathy besides pharmacological and non-pharmacological measures?
  • Symptomatic
    • 🍒What is the pharmacological management for symptomatic hypertrophic cardiomyopathy